Pancreatic Cancer Cell Genetics and Signaling Response to Treatment Correlate with Efficacy of Gemcitabine-Based Molecular Targeting Strategies

被引：0
|
作者：
Bryan Holcomb
Michele T. Yip-Schneider
Jesus M. Matos
Jennifer Dixon
Jason Kennard
Julie Mahomed
Rajasubramaniam Shanmugam
Judith Sebolt-Leopold
C. Max Schmidt
机构：
[1] Indiana University School of Medicine,Department of Surgery
[2] Indiana University School of Medicine,Departments of Biochemistry/Molecular Biology
[3] Indiana University School of Medicine,Walther Oncology Center
[4] Indiana University Cancer Center,Department of Hematology and Oncology
[5] Richard L. Roudebush VA Medical Center,undefined
[6] Indiana University School of Medicine,undefined
[7] Pfizer,undefined
[8] Inc.,undefined
来源：
Journal of Gastrointestinal Surgery | 2008年 / 12卷
关键词：
Pancreatic cancer; NF-κB; PI3 kinase; MAP kinase; Gemcitabine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：288 / 296
页数：8
相关论文
共 50 条
  • [1] Pancreatic cancer cell genetics and signaling response to treatment correlate with efficacy of gemcitabine-based molecular targeting strategies
    Holcomb, Bryan
    Yip-Schneider, Michele T.
    Matos, Jesus M.
    Dixon, Jennifer
    Kennard, Jason
    Mahomed, Julie
    Shanmugam, Rajasubramaniam
    Sebolt-Leopold, Judith
    Schmidt, C. Max
    JOURNAL OF GASTROINTESTINAL SURGERY, 2008, 12 (02) : 288 - 296
  • [2] Gemcitabine-based combination treatment of pancreatic cancer
    Heinemann, V
    SEMINARS IN ONCOLOGY, 2002, 29 (01) : 25 - 35
  • [3] Genomic Testing for Gemcitabine-Based Treatment of Pancreatic Cancer
    Zhang, Jianliang
    Hochwald, Steven N.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (05):
  • [4] Tolerance and efficacy of gemcitabine and gemcitabine-based regimens in elderly patients with advanced pancreatic cancer
    Marechal, Raphael
    Demols, Anne
    Gay, France
    de Maertelaer, Viviane
    Arvanitaki, Marianna
    Hendlisz, Alain
    Van Laethem, Jean-Luc
    PANCREAS, 2008, 36 (03) : E16 - E21
  • [5] Treatment of metastatic and/or unresectable pancreatic cancer with gemcitabine-based chemotherapy
    Samelis, GF
    Zografos, G
    Areovimata, A
    Kitsou, V
    Papakostas, P
    ANNALS OF ONCOLOGY, 2005, 16 : 324 - 324
  • [6] Efficacy and tolerance of gemcitabine-based regimens in elderly patients with advanced pancreatic cancer
    Marechal, Raphael
    Demols, Anne
    Gay, France
    Arvanitakis, Marianna
    Hendlisz, Alain
    Van Laethem, Jean-Luc
    ANNALS OF ONCOLOGY, 2006, 17 : 326 - 326
  • [7] Pancreatic Proteolytic Enzyme Therapy Compared With Gemcitabine-Based Chemotherapy for the Treatment of Pancreatic Cancer
    Chabot, John A.
    Tsai, Wei-Yann
    Fine, Robert L.
    Chen, Chunxia
    Kumah, Carolyn K.
    Antman, Karen A.
    Grann, Victor R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (12) : 2058 - 2063
  • [8] Gemcitabine-Based Chemoradiotherapy Enhanced by a PARP Inhibitor in Pancreatic Cancer Cell Lines
    Waissi, Waisse
    Ame, Jean-Christophe
    Mura, Carole
    Noel, Georges
    Burckel, Helene
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (13)
  • [9] The safety and efficacy of Onivyde (irinotecan liposome injection) for the treatment of metastatic pancreatic cancer following gemcitabine-based therapy
    Passero, Frank C., Jr.
    Grapsa, Dimitra
    Syrigos, Kostas N.
    Saif, Muhammad Wasif
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (07) : 697 - 703
  • [10] Role of concurrent gemcitabine-based chemoradiation and regional nodal irradiation in the treatment of locally advanced pancreatic cancer - Response
    Li, CP
    Chao, Y
    Yen, SH
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (03): : 1009 - 1010
12345